Transforming growth factor-α expression in benign and malignant human prostatic disease
Transforming growth factor-α expression in benign and malignant human prostatic disease
复制标题
转化生长因子-α在良性和恶性人类前列腺疾病中的表达
DOI:
10.1177/172460089200700104
复制
发表时间:
1992
期刊:
影响因子:
--
通讯作者:
Leakey Re
中科院分区:
文献类型:
--
作者:
S. Lloyd;Brown Il;Leakey Re
Investigation of biological variables in prostatic disease may not only prevent patients with a good prognosis being overtreated, but allow better selection of appropriate therapy, and may identify potential targets for novel therapies. This study investigates the growth factor transforming growth factor-α (TGFα) expression in benign and malignant prostatic biopsies using both radioimmunoassay and immunohistochemistry, considering its role in malignant epithelial transformation and as a prognostic indicator. Biochemical methods were less satisfactory than the more selective immunohistochemical methods, due to the heterogeneity of prostatic tissue. Seventy-one percent of benign biopsies (range 0-18.62ng/mg DNA) and 69% of malignant biopsies (range 0-11.1ng/mg DNA) had detectable levels of TGFα using radioimmunoassay. Immunohistochemical staining for TGFaL identified expression in 15% of benign (4 out of 27) and 53% malignant biopsies (18 out of 34). Positive staining was also identified in premalignant lesions and within stromal elements, thus implying the factor's role in autocrine/paracrine growth and/or malignant transformation. Immunostaining for TGFα may enhance detection of premalignant lesions and small foci of malignant glands which are otherwise difficult to identify using standard histopathological techniques.